Early Azithromycin Treatment to Prevent Severe Lower Respiratory Tract Illnesses in Children
Katherine E. Fleming-Dutra, Cindy R. Friedman, Lauri A. Hicks
Abstract
Katherine E. Fleming-Dutra, Cindy R. Friedman, Lauri A. Hicks
Abstract
The study by Dr Bacharier and colleagues1 found that using azithromycin in preschool children with a history of wheezing and respiratory tract infection (RTI) prevented progression to “severe” lower respiratory tract illness (LRTI). The authors defined severe LRTI as needing intensive rescue albuterol treatments; it was not defined as pneumonia, the classic definition of severe LRTI. Although azithromycin limited the need for intensive rescue albuterol, it did not prevent urgent care or emergency visits, hospitalizations, or future RTI episodes, arguably the most important prevention outcomes.
OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The study by Dr Bacharier and colleagues1 found that using azithromycin in preschool children with a history of wheezing and respiratory tract infection (RTI) prevented progression to “severe” lower respiratory tract illness (LRTI). The authors defined severe LRTI as needing intensive rescue albuterol treatments; it was not defined as pneumonia, the classic definition of severe LRTI. Although azithromycin limited the need for intensive rescue albuterol, it did not prevent urgent care or emergency visits, hospitalizations, or future RTI episodes, arguably the most important prevention outcomes.
Key concepts: Medicine, Azithromycin, Respiratory tract infections, Intensive care medicine, Respiratory tract, Pediatrics, Respiratory system, Internal medicine